web analytics
Hutchison China Meditech

Based on an update from our preferred small cap tip sheet, Small Company Share Watch, we passed an eye over an old Investor Trader favourite, Hutchison China Meditech. We liked what we saw. Huthcison is an interesting proposition on many levels. Its focus is on researching, developing, manufacturing and supplying health-oriented consumer products – primarily to the Chinese markets – which it achieves through three divisions: a healthcare division, a research and development division and a consumer products division. It's this mix of underlying profitability from a flourishing healthcare division (the latest interims (pdf) showed revenues up 25% and a 97% growth...

Asian Citrus Holdings

We first squeezed a little Asian Citrus into our portfolio back in October 2009, taking up 254 shares in China's largest orange plantation owner and operator at £4.27 a share. Before we had time to shake the tree a ten for one stock split was in the works which multiplied our holding by ten to 2,540 shares (and divided each shares worth by that very same multiple). I like a stock split. I know splitting a stock is often nothing more than a venture in rhetoric but what it does do is produce news (although when a stock split is coupled...

Sale – Hutchison China Meditech

The first of our eight transactions for late December 2010 was the sale of another tranche of Hutchison China Meditech. We bought in to HCM.L in July 2010, taking up 520 shares at £3.14 a share. We first took profit earlier in December selling 220 shares at £5.10 and then again with this more recent sale of 100 shares at £4.95. Our original outlay (excluding dealer costs) was £1,632.80 and our two December sales have netted £1,122.00 and £495.00 respectively or £1,617.00 in total. In effect we've re-couped our original investment and we still own 200 shares which are currently trading at five...

Sale – Hutchison China Meditech

With a handful of shares on my must-have before Christmas list we chopped the top off a few of our more profitable holdings last week. This is never easy to do, especially when you know there's more to come. I'm a big fan of letting the good ones run (unfortunately I've been known to let the bad ones run too - see Cosalt - though I'm assured there's good news to come...

Sale – Renesola

With last rites being performed on Renesola's AIM listing before shifting their focus solely to their New York Stock Exchange listing, last Thursday 4th November we sold off our final tranche of 500 shares of our portfolio stalwart for 4.0150 pence a share and a total return of £2,007.50 before dealer costs. We were averaged into Renesola at £1.12 a share so we took a 350% profit on Renesola this time round. Renesola has always been good to me over the years. Taking me up toward the giddy heights of £7 before I lost my nerve and smacked the sell key...

Sale – A Little More Renesola

So we pulled the trigger on Renesola and sold off 500 shares - half our holding - last Wednesday at a price of £3.5375 per share. The reasoning: well, besides SOLA.L pushing some two year highs, we're working to a little bit of a deadline  before Renesola dumps its AIM listing and takes all of its toys to New York. So whilst it's always nice to bank a triple-bagger (we are averaged into Renesola at £1.1227 per share) there's still a sense of loss at what could have been. Put it this way. If Renesola's move away from AIM wasn't...

Renesola and Another Dear John Letter

Readers of Investor Trader may remember my brief tryst with West China Cement which came to a premature end back in May of this year. Sadly, growth saw them forget their roots, pull their AIM listing and try to make it in the big city. In this case, the big city being Hong Kong. And as it turns out, the big city has been quite kind witnessing gains in WCC in excess of 20% in the month since they headed east. I was willing to take that one on the chin. Let bygones be bygones and all that. Until...

Purchase – Hutchison China Meditech

Anyone who's dropped by Investor Trader more than once over the journey would know of my penchant for Chinese investments. I have no defense. In the short time we've been online we've held Renesola, West China Cement, China Biodiesel and Asian Citrus. Hell, even Synergy Health had a Chinese interest. That's a fair slice of China in our investment pie. China may be a juggernaut that's cooled its jets a little of late (purposefully I might add) but the massive potential for a well-managed Chinese company constantly has me on the lookout for more. So after a little homework it'll come as...

China Biodiesel Tender Offer and Delisting

And trust me, it is a tender offer. After purchasing our initial tranche of 1,960 China Biodiesel shares back in July 2009 for 6.6 pence a share and topping up a short week later at 10.06 pence (yep that's a 50% rise in that short week), we were averaged into CBI.L at 9.29 pence a share. And whilst the share price did go on to test 20 pence in August 2009, since then there's been a lot of market apathy - time spent between 8 and 14 pence. Lately it's split the middle of those highs and lows and has camped...

A Little Renesola Profit Taking

A few days back I wrote about Renesola testing new recent highs in the lead-up to results and how the situation in Greece threw a bit of spanner into the works. Well results have come and gone, and not bad results at that, but having a bit of a conservative edge about me of late, I took a little profit, realising 400 shares at £2.41 a share for a return before costs of £964. We were averaged into Renesola at £1.12 so we more than doubled our money and we've still got 1,000 SOLA's sitting in our portfolio mix. There are...

West China Cement – A Love Story

It's with a heavy heart that today I write about my sale of West China Cement. Our brief love affair - this time around, for we have loved before - began in July 2009 when I picked up 153 of these little grey beauties at £1.70. Watching our love take flight, two short weeks later I added another 221 shares at an already soaring £2.57. My 374 shares were averaged in at £2.21, for a total outlay of £828.21 before costs. Ahhh, the early days of a relationship. At the dawn of our wonderful time together West China Cement surged through £3...

Cement’s Taking Off

Early last week West China Cement caught my eye after finishing the day up 34 pence at 490 pence, a rise of a little over 7% on the day. At that point after a little positive pondering, I postulated that if WCC could breach the 5 quid mark that week and remain there - remaining there's a biggy - then it could be onward and upward for West China Cement in the coming weeks and months.  Well, it not only breached the 5 quid mark it smashed that particular ceiling finishing the week at 585 pence, up a chunky 125 pence from the...